HYPR OBI Trademark

Trademark Overview

On Tuesday, January 28, 2025, a trademark application was filed for HYPR OBI with the United States Patent and Trademark Office. The USPTO has given the HYPR OBI trademark a serial number of 99020582. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, July 24, 2025. This trademark is owned by OBI PHARMA, INC.. The HYPR OBI trademark is filed in the Pharmaceutical Products category with the following description:

Immunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorga...
hypr obi

General Information

Serial Number99020582
Word MarkHYPR OBI
Filing DateTuesday, January 28, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, July 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the black stylized wording "HYPR" and the teal stylized wording "OBI" with a teal curved line below "OBI".
Goods and ServicesImmunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorganisms for medical purposes
Indication of Colors claimedThe color(s) The wording "HYPR" appear in black and the wording "OBI" appear in teal, and the downward curve appear under the word "OBI" appear in teal. is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOBI PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City
TW

Trademark Events

Event DateEvent Description
Tuesday, January 28, 2025NEW APPLICATION ENTERED
Monday, June 30, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 28, 2025APPLICATION FILING RECEIPT MAILED
Monday, June 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 8, 2025ASSIGNED TO EXAMINER
Thursday, July 24, 2025NON-FINAL ACTION E-MAILED
Thursday, July 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 24, 2025NON-FINAL ACTION WRITTEN

Related Keywords

hypr preparations pharmaceutical purposes treatment cancer medical products chemical suppressing diseases